Huh Hoyoung — SEC insider filings
SEC reporting owner CIK 1401267. 23 insider filings on record with FilingPulse; latest filed 2026-10-16.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2021-06-30 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 22 legs across 7 filings — 340,250 shares, $23,991 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: purchase of 56,100 shares @ $0.26 ($14,306) in Peak Bio, Inc., filed 2023-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Peak Bio, Inc. (PKBO) | Director, 10% owner | 13 | 22 legs · 340,250 sh · $23,991 | — | 17 |
| Akari Therapeutics Plc (AKTX) | Director, 10% owner | 4 | — | — | 13 |
| PLIANT THERAPEUTICS, INC. (PLRX) | Director | 6 | — | — | 6 |
Insider filings — Huh Hoyoung
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-16 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 17,249 @ $7.90 · Grant/award (A): 6,160 @ $7.90 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Akari Therapeutics Plc (AKTX) | Purchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 3,093,293 (derivative) · Purchase (P): 3,093,293 (derivative) @ $0.40 | EDGAR |
| 2025-06-09 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Akari Therapeutics Plc (AKTX) | Grant/award (A): 892,857 @ $1.12 · Grant/award (A): 892,857 (derivative) @ $1.12 · Grant/award (A): 892,857 (derivative) @ $1.12 | EDGAR |
| 2024-11-18 | 4 | Peak Bio, Inc. (PKBO) | Conversion (C): 4,574,661 · Disposition to issuer (D): 4,574,661 · Disposition to issuer (D): 8,382,742 · Disposition to issuer (D): 372,940 · Conversion (C) · Disposition to issuer (D): 176,292 (derivative) · +1 more | EDGAR |
| 2024-06-17 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 26,764 (derivative) @ $0 | EDGAR |
| 2023-09-25 | 4 | Peak Bio, Inc. (PKBO) | Purchase (P): 45,000 | EDGAR |
| 2023-09-21 | 4 | Peak Bio, Inc. (PKBO) | Purchase (P): 50,000 · Purchase (P): 30,000 | EDGAR |
| 2023-09-19 | 4 | Peak Bio, Inc. (PKBO) | Purchase (P): 25,000 | EDGAR |
| 2023-09-15 | 4 | Peak Bio, Inc. (PKBO) | Purchase (P): 30,000 · Purchase (P): 20,000 | EDGAR |
| 2023-09-13 | 4 | Peak Bio, Inc. (PKBO) | Purchase (P): 30,000 · Purchase (P): 17,000 | EDGAR |
| 2023-09-12 | 4/A | Peak Bio, Inc. (PKBO) | Purchase (P): 0 @ $0 · Purchase (P): 0 @ $0 · Purchase (P): 0 @ $0 · Purchase (P): 0 @ $0 · Purchase (P): 0 @ $0 · Purchase (P): 0 @ $0 · +1 more | EDGAR |
| 2023-09-01 | 4 | Peak Bio, Inc. (PKBO) | Purchase (P): 5,500 @ $0.25 · Purchase (P): 1,000 @ $0.25 · Purchase (P): 2,500 @ $0.26 · Purchase (P): 3,750 @ $0.25 · Purchase (P): 11,400 @ $0.27 · Purchase (P): 56,100 @ $0.26 · +1 more | EDGAR |
| 2023-08-15 | 4 | Peak Bio, Inc. (PKBO) | Option exercise/expiry (X): 583,333 @ $0.60 · Option exercise/expiry (X): 583,333 (derivative) @ $0 | EDGAR |
| 2023-07-21 | 4 | Peak Bio, Inc. (PKBO) | Option exercise/expiry (X): 458,333 @ $0.60 · Option exercise/expiry (X): 458,333 (derivative) @ $0 | EDGAR |
| 2023-06-27 | 4 | Peak Bio, Inc. (PKBO) | Option exercise/expiry (X): 666,667 @ $0.60 · Option exercise/expiry (X): 666,667 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Peak Bio, Inc. (PKBO) | Grant/award (A): 1,884,625 (derivative) · Grant/award (A) @ $1,130,775 | EDGAR |
| 2022-11-03 | 4 | Peak Bio, Inc. (PKBO) | Other (J): 6,442,438 @ $0 · Other (J): 372,562 @ $0 | EDGAR |
| 2022-06-21 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-06-30 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 13,286 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1401267 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs